PAPER Timmer NM, Kuiperij HB, de Waal RM, Verbeek MM
SEARCH RESULTS
330988 RESULTS
PAPER Reesink FE, Lemstra AW, van Dijk KD, Berendse HW, van de Berg WD, Klein M, Blankenstein MA, Scheltens P, Verbeek MM, van der Flier WM
CSF α-synuclein does not discriminate dementia with Lewy bodies from Alzheimer's disease.
J Alzheimers Dis. 2010;22(1):87-95. PubMed: 20847452PAPER Yakushev I, Bartenstein P, Siessmeier T, Hiemke C, Scheurich A, Lotz J, Fellgiebel A, Müller MJ
Cerebrospinal fluid tau protein levels and 18F-fluorodeoxyglucose positron emission tomography in the differential diagnosis of Alzheimer's disease.
Dement Geriatr Cogn Disord. 2010;30(3):245-53. Epub 2010 Sep 15 PubMed: 20847555PAPER Wattmo C, Wallin ÅK, Londos E, Minthon L
Long-term outcome and prediction models of activities of daily living in Alzheimer disease with cholinesterase inhibitor treatment.
Alzheimer Dis Assoc Disord. 2011 Jan-Mar;25(1):63-72. PubMed: 20847636PAPER Llano DA, Laforet G, Devanarayan V,
Derivation of a new ADAS-cog composite using tree-based multivariate analysis: prediction of conversion from mild cognitive impairment to Alzheimer disease.
Alzheimer Dis Assoc Disord. 2011 Jan-Mar;25(1):73-84. PubMed: 20847637PAPER Sjölander A, Zetterberg H, Andreasson U, Minthon L, Blennow K
BACE1 gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease.
Mol Neurodegener. 2010;5:37. PubMed: 20849576PAPER Yamamoto-Watanabe Y, Watanabe M, Jackson M, Akimoto H, Sugimoto K, Yasujima M, Wakasaya Y, Matsubara E, Kawarabayashi T, Harigaya Y, Lyndon AR, Shoji M
Quantification of cystatin C in cerebrospinal fluid from various neurological disorders and correlation with G73A polymorphism in CST3.
Brain Res. 2010 Nov 18;1361:140-5. PubMed: 20849835PAPER Ubhi K, Peng K, Lessig S, Estrella J, Adame A, Galasko D, Salmon DP, Hansen LA, Kawas CH, Masliah E
Neuropathology of dementia with Lewy bodies in advanced age: a comparison with Alzheimer disease.
Neurosci Lett. 2010 Nov 26;485(3):222-7. PubMed: 20849919PAPER Morillas-Ruiz JM, Rubio-Perez JM, Albaladejo MD, Zafrilla P, Parra S, Vidal-Guevara ML
Effect of an antioxidant drink on homocysteine levels in Alzheimer's patients.
J Neurol Sci. 2010 Dec 15;299(1-2):175-8. PubMed: 20850133PAPER Michel BF, Luciani V, Geda YE, Sambuchi N, Paban V, Azorin JM
[In Alzheimer's disease, the clinical expression of behavioral and psychological signs and symptoms is early and specific of neuropathological stages].
Encephale. 2010 Sep;36(4):314-25. PubMed: 20850603PAPER Fujishiro H, Iseki E, Higashi S, Kasanuki K, Murayama N, Togo T, Katsuse O, Uchikado H, Aoki N, Kosaka K, Arai H, Sato K
Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia.
Neurosci Lett. 2010 Dec 3;486(1):19-23. PubMed: 20851165PAPER McMillan PJ, Leverenz JB
From model system to clinical medicine: pathophysiologic links of common proteinopathies.
Alzheimers Res Ther. 2010;2(5):26. PubMed: 20854651PAPER Ito-Harashima S, Kuroha K, Tatematsu T, Inada T
Translation of the poly(A) tail plays crucial roles in nonstop mRNA surveillance via translation repression and protein destabilization by proteasome in yeast.
Genes Dev. 2007 Mar 1;21(5):519-24. PubMed: 17344413PAPER Wilson MA, Meaux S, van Hoof A
A genomic screen in yeast reveals novel aspects of nonstop mRNA metabolism.
Genetics. 2007 Oct;177(2):773-84. PubMed: 17660569PAPER Lu J, Deutsch C
Electrostatics in the ribosomal tunnel modulate chain elongation rates.
J Mol Biol. 2008 Dec 5;384(1):73-86. PubMed: 18822297Current Filters
No filters selected